Fertility Treatment in Korea for International Patients: IVF, Egg Freezing, and What to Expect

For couples who have spent months navigating fertility clinics at home — absorbing waitlists, opaque pricing, and the particular exhaustion of receiving the same protocol cycle after cycle — Korea represents something different: a fertility ecosystem where IVF live-birth rates consistently rank among the highest in the OECD, where a full stimulation cycle with egg retrieval and blastocyst culture costs between $2,800 and $5,200 USD (compared to $15,000–$25,000 in the United States), and where the waiting time from initial consultation to first retrieval is typically measured in weeks, not months.

This guide is for international patients seriously considering fertility treatment in Korea — not a catalog of clinics, but a practical account of what the process actually looks like from arrival to embryo transfer, grounded in how Korea’s fertility system is structured and what it will ask of you.

Why Korea’s Fertility Numbers Are Real

Korea’s IVF success rates are not marketing copy. The Ministry of Health and Welfare (MOHW) publishes annual IVF outcome data across all licensed fertility clinics in the country — something most healthcare systems do not do. The 2023 MOHW fertility treatment report (covering approximately 110,000 cycles performed that year) recorded a national average live-birth rate of 31.4% per retrieval for patients under 35, with leading specialty clinics — CHA Medical Group, Maria Fertility Hospital, Mizmedi Hospital — reporting rates 5–8 percentage points above that average for the same cohort.

What drives this performance is partly structural: Korea has more fertility specialists per capita than any other OECD country except Israel, and the Korean Society for Reproductive Medicine (KSRM) mandates continuing education and protocol standardization across licensed centers. Labs are inspected regularly. Embryologists are credentialed separately from OB/GYNs. The result is that even a mid-tier Korean fertility clinic operates at a level of technical rigor that would qualify as a specialist center in most Western countries.

The Core Landscape: Where International Patients Go

Three names appear in nearly every Korean fertility conversation with international patients:

CHA Medical Group is the largest fertility network in Korea, operating full-cycle IVF programs at CHA Bundang Medical Center (Seongnam, 30 minutes south of Seoul), CHA Gangnam Medical Center, and CHA Ilsan Medical Center. CHA Bundang is particularly well-regarded for difficult cases — low ovarian reserve (AMH < 0.5 ng/mL), recurrent implantation failure, and preimplantation genetic testing (PGT). Their international patient coordinator team handles translation, scheduling, and protocol explanations in English, Arabic, and Mandarin. CHA Medical Group is KHIDI-registered as a medical tourism facility and holds international patient accreditation under Korea’s MOHW framework.

Maria Fertility Hospital (Dongdaemun, Seoul) is Korea’s oldest dedicated IVF clinic, founded in 1985, and the institution that trained a significant share of Korea’s practicing reproductive endocrinologists. Maria is a single-specialty center — nothing but fertility — which concentrates the lab capacity and clinical attention. Success rates for frozen embryo transfer (FET) cycles are among the highest published in Korea. Maria has an English-language international patient intake process and works with KHIDI-registered medical tourism facilitators.

Mizmedi Hospital (Mapo-gu, Seoul) is smaller than CHA or Maria but has a reputation among international patients for personalized coordinator relationships and a strong track record in egg freezing and oocyte cryopreservation — a growing segment for patients in their early 30s who are not yet trying to conceive. Wait times at Mizmedi are typically shorter than at the larger networks.

Beyond the Seoul core, Inje University Haeundae Paik Hospital in Busan has an active fertility program and is the natural choice for patients coming through Gimhae International Airport who prefer to stay outside Seoul.

What the Process Actually Looks Like

International patients typically follow this sequence:

Pre-travel (4–6 weeks before arrival): You send your existing fertility workup — AMH, antral follicle count (AFC), semen analysis if applicable, prior cycle records — to the clinic’s international coordinator. The coordinator shares these with the reproductive endocrinologist who will manage your case. A preliminary protocol recommendation (antagonist, agonist long, mini-IVF, etc.) comes back within 5–7 business days. This is not a binding commitment, but it lets you plan your travel window with your actual menstrual cycle in mind.

Arrival consultation (Day 1–2): Your first appointment is a baseline ultrasound plus bloodwork to confirm your hormone levels match the pre-travel workup. The doctor reviews the protocol with you directly. In most Korean fertility clinics, the reproductive endocrinologist you see at consultation is the one performing your retrieval — not a rotating attending.

Stimulation phase (8–12 days): Daily self-injections, typically a GnRH antagonist protocol (Cetrotide or Ganirelix alongside FSH). You return to the clinic every 2–3 days for monitoring ultrasounds and estradiol checks. This is where staying close to the clinic matters — clinics in Gangnam or Bundang are typically 20–40 minutes from the main international patient hotel clusters in central Seoul.

Retrieval and fertilization: Egg retrieval is a day procedure under sedation, typically early morning. ICSI (intracytoplasmic sperm injection) is used in most international patient cases as standard practice. Fertilization results come back the next morning. Blastocyst culture continues for 5–6 days; clinics performing PGT-A (preimplantation genetic testing for aneuploidy) biopsy embryos on Day 5 or 6.

Transfer or freeze: Fresh transfers happen approximately 5 days post-retrieval if indicated; many international patient cycles freeze all viable blastocysts for a subsequent FET, either in Korea on an extended stay or via embryo shipping (more on this below).

The Visa Question

Medical tourists seeking fertility treatment in Korea use the C-3-3 Medical Tourism Visa, which allows stays of up to 90 days for treatment and recovery. Accompanying spouses or partners apply under the same category as caregivers. Citizens of 112 countries can enter Korea visa-free for up to 90 days under the standard visa-waiver program — in practice, many patients from Nigeria, Ghana, Saudi Arabia, the UAE, and Malaysia travel without a specific medical visa. Korea Immigration Service (KIS) does not require a C-3-3 visa to receive medical treatment; the visa is primarily useful for patients whose home country requires a medical visa record for travel approval or insurance purposes.

Patients needing more than one cycle across multiple trips can reuse the visa-waiver entry for subsequent visits, provided stays are within the allowable window. Your KmedTour coordinator can advise based on your specific passport.

Embryo Shipping: Taking Frozen Embryos Home

A question that comes up in almost every fertility consultation with international patients: can frozen embryos be shipped back to my home country?

The answer depends on your destination country’s regulations, not Korea’s. Korea’s MOHW permits embryo export with patient consent and documentation from the treating clinic. Receiving countries — particularly in the Middle East and parts of Africa — have variable rules on accepting imported embryos for transfer. Saudi Arabia, for example, generally requires that both sperm and egg come from a married couple and prohibits donor cycles, while the UAE’s regulations differ by emirate.

CHA Medical Group and Maria Fertility Hospital both have experience navigating embryo shipping logistics for international patients and can provide the required MOHW-certified documentation. Budget 3–4 weeks for the coordination process and confirm your home clinic’s requirements before your Korean cycle begins.

Realistic Costs (2026 reference points)

Medications (FSH, GnRH antagonist) are purchased at Korean pharmacies and typically add $800–$1,800 depending on dosage protocol — significantly cheaper than US pharmacy prices. Consultation fees at KHIDI-registered clinics are generally $100–$200 for the initial visit.

What Makes a Good Candidate for Korean Fertility Tourism

Korea’s system rewards patients who are organized about their existing records, flexible enough to travel on a cycle-dependent schedule (egg retrieval cannot be planned to the day), and willing to stay for at least 2–3 weeks for a retrieval cycle. Patients with a clear diagnosis (PCOS, endometriosis, male factor, low AMH) who have not yet responded well to domestic protocols often see the biggest benefit — Korea’s lab quality and the density of clinical expertise are most visible in complex cases.

For couples earlier in the diagnostic process, a Korea visit that combines initial consultation with a baseline workup can compress 6–8 weeks of scheduling in their home country into a single 10-day trip.

Getting Started

KmedTour works with KHIDI-registered Korean fertility clinics and can match patients with a clinic based on their specific diagnosis, budget, and target city. The patient intake form at /patient-intake takes 10 minutes; a coordinator follows up within 24–48 hours with clinic options and next steps. There is no cost for the initial matching process.